Skip to main content

Table 2 Overview of different variables in Pimobendan- and placebo-group

From: Effect of Pimobendan on NT-proBNP and c troponin I before and after a submaximal exercise test in dogs with preclinical mitral valve disease without cardiomegaly – a randomised, double-blinded trial

Variable Pimobendan Placebo
Number 10 10
Gender (M/F) 7/3 3/7
Age (years, mean ± SD) 10.3 ± 2.8 8 ± 2.8
Weight (kg, mean ± SD) 14 ± 7.7 17.3 ± 8.7
Murmur (I/II/III/IV) 5/2/0/3 5/4/0/1
Speed (km/h, mean ± SD) 5.5 ± 1.3 5.7 ± 1.3
  1. This table shows the number of dogs (n), gender (M/F), age (years; mean ± standard deviation (SD)), weight (kg; mean ± SD), heart murmur (grades I-VI/VI), and the speed running on the treadmill (km/h; mean ± SD) of Pimobendan- and placebo-group. The Pimobendan dose (mg/kg/d; mean ± SD) is also shown